# Aurinia Renal Response in Active Lupus With Voclosporin

> **NCT03021499** · PHASE3 · COMPLETED · sponsor: **Aurinia Pharmaceuticals Inc.** · enrollment: 358 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Voclosporin
- **DRUG:** Placebo Oral Capsule

## Key facts

- **NCT ID:** NCT03021499
- **Lead sponsor:** Aurinia Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-17
- **Primary completion:** 2019-09-24
- **Final completion:** 2019-10-10
- **Target enrollment:** 358 (ACTUAL)
- **Last updated:** 2023-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03021499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03021499, "Aurinia Renal Response in Active Lupus With Voclosporin". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03021499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*